AZD5213 + pregabalin

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Diabetic Neuropathy, Painful; Diabetic Neuropathies

Drug Information

Target Indication

Diabetic Neuropathy, Painful; Diabetic Neuropathies

Clinical Trial

Last updated: 4/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

AZNCF

ASTRAZENECA PLC

Related Pipeline

Hypercholesterolemia

Triple Negative Breast Neoplasms

Generalized Anxiety Disorder

Metastatic Castration-resistant Prostate Cancer

Diabetes Mellitus, Type 2